Neuro Exam 2 Flashcards

1
Q

Tripans mechanism

A

agonist for 5HT receptor to cause
vasoconstriction of cerebral vessels
inhibition of peptide release to cause vasodilation, inflammation, pain
prevent activation of pain fibers in trigeminal n.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sumatripan

A

first line tripan used to treat moderate to severe migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Absorption route of triptans

A

Oral, nasal, sc (only sumatriptan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

distribution Triptans

A

low lipid solubility, poor CNS penetration. newer ones are more liophilic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

half life tripans

A

2-4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adverse effects - Triptans

A

Paresthesia, flushing, dizziness, drowsy.

Seriouds: coronary vasospasm, agina, MI, arrhythmia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Precautions with Triptans

A

coronary, arterial disease, uncontrolled htn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Drug interactions - triptan

A

not with 24 hours of Ergot Alkaloid due to additive vasoconstriction
Not at same time of MAO I, SSRIs, or SNRIs - serotonin syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ergot Alkaloids mechanism

A

agonist of 5Ht receptor - similar to triptan mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dihydroergotamine

A

ergot alkaloid

intranasal, parenteral.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ergotamine

A

ergot alkaloid
Oral, sublingual, rectal.
Poor oral bioavalibiliy - slow onset - long duration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ergotamine+caffine

A

ergot alkaloid

added to increase absorption, still less than tripans.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ergot Alkaloid uses

A

terminating moderate to severe migraines.
less effective and more toxic than triptans - 2nd line.
Used in pts with duration >48 hrs or frequent recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Adverse effects of ergot alkaloids

A

mild: N, V, D, parasthesias, vertigo
Severe: vascular occlusion, gangrene (due to alpha1 AR receptors stimulated) - associated with overdose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drug interactions - ergot alkaloid

A

avoid use with nonselective Beta blockers - severe peripheral ischemia
not used within 24 hrs of tripan
contraindicated with CYP3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Migraine Prevention treatment

A

prophylaxis for severe frequent (>4 month), long lasting (>12 hours), or disabling.
No single med is a clear choce, and takes 3-4 weeks to take effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Migraine Prophylaxis

A
Antihypertensives - BB, calcium channel, ACEI
Antidepressants
anticonvulsants
Botox
Metbysergide
NSAIDs
Dietary Supplements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Beta Blocker

A

Propanolol - migraine prevention first line.

used for continuous prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Beta Blocker - side effects

A

fatigue, exercise intolerance, depression, orthostatic hypotension.
contraindicated - asthma, diabetes, CHF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Calcium channel blockers

A

Verapamil - Third line prophylaxis for migraines
effectivness is limited.
Should not be used with BB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ACE I

A

Second or third line for Migraine prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Tricyclic Antidepressants

A

Amitriptyline - second line for migraine prophylaxis. and can be given to pts with insomnia or depression.
SE: sedation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Anticonvulsants

A

Valproate and topiramate - first line - similar to propanolol
Gabapentin - third line for migraine prophylaxis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Valproate

A

anticonvulsant used for migraine prevention

causes nasuea, tremor, eight gain, hair loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Topiramate

A

anticonvulsant for migraine prevention

causes parasthesias, langauage and cognitive impariment, weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Botox

A

second line treatment for chronic migraine (>15 per month)

causes HA, neck pain, muscle weakness, ptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Methysergide

A

serotonin receptor antagonist - 5HT blocker to block vasoconstriction to iniate migraine.
effective but high toxicity - N, V, D, retroperitoneal, heart valve fibrosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

NSAIDs - migrain prophylaxis

A

short term migraine pregention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Dietary supplements in migraine prophylaxis

A

Riboflavi - Vit B2
Butterbur - antispasmatic vascular wall, anti-inflammatory
Feverfew

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Sources of Opiods

A
Plants - opium poppy
Animals
1) Enkephalin 
2) endorphins
3) dynorphin
4) endomorphins
5) nocicptin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Enkephalin

A
endogenous opioid
modulates NT at synpase (short distance) with rapid breakdown.
Found in brain and spinal cord.
Met-Enkephalin
Leu-Enkephalin
Derived from pro-enkephalin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Endorphin

A

endogenous opioid that acts on NT and as a hormone
derived from proopiomelatocortin
Found in hypothalamus and pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Beta - Endorphin

A

a 31 AA, most active endorphin that contains a Met-Enkephalin a amino terminal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Dynorophin

A

endogenous opioid
unsure of role
derived from pre-dynorphin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Dynorphin A

A

biologically kappa selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Endomorphins

A

new endogenous opioids, not well characterised.
variation on opioid motif
Tyr-Pro-Trp/Phe-Phe
Mu receptor selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Nociceptins

A

regulate pain tranmission but act on different receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Naloxone

A

blocks opioids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Mu receptors

A

cause analgesia and respiratory depression.
endo: beta endorphin and enkephalins
Morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Delta receptor

A

analgesia only
Endo: beta endorphin and enkephalins
NO drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Kappa receptor

A

spinal analgesia
dynorphin A
drug: pentazocine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Mechanism of mu receptor

A

1) via B-gamma cose VGCC on presynaptic Neuron to decrease NT release
2) via beta-gamma activate GIRK - K channels - to hyperpolarize Pre or Post
3) via Gi/o decrase cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Analgesic actions of opioids

A

1) inhibition of ascending pain pathway
2) activation of descending pain pathway
3) subjective response to pain

44
Q

how do opioids inhibit ascending pain pathway

A

decrease presynaptic NT release in Dorsal horn of Substance P and glutamate
Inhibit excitatory post synaptic spinothalamic neurons

45
Q

how to opioids excite descending pain pathway

A

activate inhibitory neurons to medulla, PAG, locus coerulus

46
Q

how do opioids control subjective pain?

A

euphoria, feel less pain, limbic system

47
Q

Do opioids releive 2nd or 1st pain better

A

2nd - dull, constant

48
Q

Behavioral consequences of opioids

A

Euphoria (mu receptors to active reward pathway), dysphoria (K receptors), sedation, behavioral excitation (acute toxicity)

49
Q

Respiratory consequences of opioids

A

decrease RR at therapuetic doses

due to decrases CO2 sensitivity in brainstem to cause incrased CO2 in blood, cerebral vasodilation –> and increased ICP

50
Q

GI effects of opioids

A

N,V - ambulatory pts.
Constipation - no tolerance
Urinary retention

51
Q

Cough effects of opioids

A

acts on cough center in medulla

Codeine - at low does as to not cause analgesic or respiratory affect.

52
Q

Dextromethorphan

A

non-analgesic opiod preffered over codeine for cough suppresion due to decrease potential for abuse, blocks NMDA recpetor - so acts like PCP or ketamine… so restricted

53
Q

Cardiovascular risks of Opioids

A

minimal, but occur indirectly through histamine - vasodilaton and decrases BP.
O decrease cardiac workloud and inhibit barorecpetor effect.
used to treat pulmonary embolism with cardiac dysfunction

54
Q

Contraindicaitons of opioids

A
respiratory dysfunction - severe
high iCP
hypotension
shock - endogenous agents already active
hypothyroidism
impaired hepatic function
55
Q

Drug interactions of opiates

A

CNS depressants - Barbiturates - additive to CNS depression and increase in metabolism
Phenothiazine - atnipsychotic - increased risk of respiratory depression, decreased BP
MAO I and tricyclic antidepressants

56
Q

which opioid agents cross BBB

A

heroine and codeine

57
Q

Metabolism of opioids

A

liver metabolism to form morphine-6-glucuronide

58
Q

Morphine

A

mu agonist

II: used for post op and acute traumatic pain

59
Q

Heroine

A

mu agonist

I - highly lipophilic, rapid onset, high abue

60
Q

Codeine

A

II or III with tylenol, mu agonist
10% of caucasians are deficient in CYP2D6 - so not as effecitve
antitussive, high toxicity in high doses

61
Q

Oxycodone

A

II
mu agonist
equipotent to morphine - high abuse rate. good oral

62
Q

Hydrocodone

A

Vicodin III

antitussive, weak analgesic - equivalent to codeine.

63
Q

Tramadol

A

U receptor agonist

blocks monoamine uptake to potentiate descending pain pathways

64
Q

Fentanyl

A
U receptor agonist
II
100X more potent than morphine
short duration of 1 hr (morphine is 4-6 hr)
requires ventilatory support. 
has transdermal patch
65
Q

Loperamide

A

imodium
antidiarrheal
low solubility so stays in GI

66
Q

Buprenorphine

A

partial mu agonist
precipitates mild withdrawal symptoms
long acting

67
Q

Methadone

A

mu receptor agonist - use to treat opioid withdrawal symptoms

68
Q

Naloxone

A

Mu receptor ANTAGONIST to block effects of endogenous opioids.

69
Q

Tolerance is due to..

A

frequence, dose, duration

70
Q

Physical Dependence

A

usually mild, and can be uliminated by taper

71
Q

psychological dependence

A

addiction - craving or desire.

due to adaptations in neuronal circuits

72
Q

Opiate withdrawal

A

flu like symptoms
dilated pupils, insomnia, rhinorrhea, sweat, N, D, cramps, chills.
Precipitated by antagonists and mixed agonists.
Tx clonidine to decreases SNS (alpha 2 agonist)
not life threatening.

73
Q

Evaluation of pain experience

A
Severity 
Behavior - learned
Cognitive - thinking process
cultural
Suration
Origin - nocicpetive vs neuropathic
74
Q

Acute v chronic pain

A

acute - resolution or healing of damaged tissue
Chronic - pain persisting longer than expected - beyond normal healing, chornic disease, without identifiable cause, cancer

75
Q

neuropathic pain

A

disengaged from noxious or healing process. caused from nerve damage

76
Q

Functional pain

A

abnormal operation of nervous system - fibromyalgia, IBS, tension type HA - hyperalgesia and allodynia

77
Q

spinobulbar tract

A

carries pain info to limbic system - emotional and motivational pain experience

78
Q

mu opioid receptors in PAG….

A

block GABA release and remove inhibition to activate PAG outfluw

79
Q

PAG activates

A

spinal enkephalin and spinal monoamine release (5HT and NE)

80
Q

mu opioid receptrs in spinal cord..

A

are activated by enkephalins to decrease glutamate and substance P release and hyperpolarize post synatpic neuron to cause analgesia

81
Q

alpha 2 ARs…

A

are located presynpatically. Activation by NE attenuates excitation of 2nd order neuron and cause analgesia.

82
Q

Drugs involved in Pain Transduction

A

NSAIDS

83
Q

Drugs involved in Pain Transmission

A

Local Anesthetics

NMDA receptor antagonists

84
Q

NMDA receptor antagonists

A

Ketamine

block glutamate receptor deplolarization - decrease transmission of nociceptive stimuli

85
Q

Modulation of transmission drugs

A

mu opioid agonsts

alpha2 AR agonists - block substance P release from primary neuron

86
Q

NSAID - action

A

inhibit COX2 and PG synthesis

transduction of pain

87
Q

LA - action

A

block VSSC

tranmission

88
Q

NMDA antagonists - action

A

block glutamate depolarization at 2nd order neurons.

Transmission to pain blocker

89
Q

Mu opioid receptor agonists - action

A

block glutamate and substance P from primary neuron
Hyperpolarize 2nd order neuron
Modulation of transmission and perception

90
Q

Alpha2 adrenergic agonist - action

A

block glutamate and substance P from primary neuorn

Modulation of tranmission

91
Q

Management of mild pain

A

non opioid +/- adjuvant analgesic

92
Q

Moderate acute pain

A

immediate release short-acting opioids with slow titration + non-opioid +/- adjuvant analgesics

93
Q

Severe acute pain

A

immediate release short acting opioids with RAPID titration + non opioid +/- adjuvant analgesics

94
Q

Multimodal analgesic

A

benefits by synergistic actions to allow lower doses and limit dose related side effects

95
Q

`Formulations of Opioids

A

Immediate release - parenteral and oral opioids
Sustained release - for morphine extended duration
Transdermal patch

96
Q

NSAIDs

A

COX2 inhibitors to interefere with inflammatory cascade at peripheral and central sites.

97
Q

Side effects of NSAIDs

A

GI ulceration, increased bleeding risk, renal dysfunction

98
Q

Acetaminophen

A

COX2 inhibitor to block central sensitization

99
Q

Alpha 2 AR agonists

A

Clonidine
acts on dorsal horn and cells and locus ceruleus to modulate tranmission
can cause hypotension, bradycardia, sedations

100
Q

Ketamine

A

NMDA antagonist in ascending pain modulatory pathway.

reduces development to tolerance in long term opioid use .

101
Q

Peripheral sensitization

A

type of neuropathic pain
damaged peripheral nerves synthesize proinflammaotry mediators to activate terminal and produce pain or render hypersensitive.

102
Q

Central sensitization

A

neuropathic pain

amplification of synaptic transfer from terminal to dorsal horn neurons by BDNF and substance

103
Q

Chronic Pain Management

A

mechanistic approach rather than therapuetic class stratification.
Enhance descending inhibitory
Decrease central sensitization and peripheral sensitization

104
Q

What drugs enhance desending inhbitiory pain pathway

A

Opioids, antidepressants (block NE, serotonin reuptake)

105
Q

What decreaeses central sensitization

A

anticonfulstants, ketamine

106
Q

what decreases peripheral sensitization

A

anticonvulsants, LA